MedTrace Logo

Sentio Systematic Evaluation

NCT07161154 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-08

No results posted yet for this study

Summary

The study is designed as an international, multi-center, single-armed, non-interventional/observational study including subjects who has received or are planned to receive the Sentio system as part of normal clinical practice.

Conditions

  • Hearing Loss, Bilateral or Unilateral
  • Hearing Loss, Conductive
  • Hearing Loss, Mixed Conductive-Sensorineural
  • Single Sided Deafness
  • Hearing Loss
  • Hearing-Impairment
  • Hearing Aid

Interventions

DEVICE

Transcutaneous bone conduction hearing system

The Sentio system is an active transcutaneous bone conduction hearing system (single armed study)

Sponsors & Collaborators

  • Oticon Medical

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2035-12-31
Completion
2035-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07161154 on ClinicalTrials.gov